| DEC-NET Serial number IT363 | | | | Published online | 08/03/2005 13.55.00 | | Last updated | 14/07/2005 16.56.16 | | | | Other protocol ID number | | | Current trial status | Planned (i.e. not yet recruiting participants) | Major Disease
(ICD9 class) | EPILEPSY UNSPECIFIED | | Experimental drug |
Levetiracetam
Treatment regimen (dosage and duration)
N/A |
| Gender | Both | | Age (range) | |
Eligibility criteria | | | | |
Trial design/methodology | | Phase | 3 | | Kind of study | Efficacy
| | Design | In aperto, non controllato, non randomizzato, a gruppi paralleli | | | | | | | | |
|
|
| Principal investigator | | Name | Roberto Gaggero | | Institution | Istituto G. Gaslini U.O. Neuropsichiatria | | Postal address | Largo G. Gaslini 5 | | City | 16147 Genova Quarto | | Country | ITALY | | Phone | ++39 010/5636 | | Fax | | | E-mail | |
| Sponsor name | | UCB S.A: Pharma Sector (Industry) |
| Participating countries | | POLAND | | BRAZIL | | CZECH REPUBLIC | | GERMANY | | UNITED KINGDOM | | MEXICO | | CANADA | | UNITED STATES | | FRANCE | | ITALY | | BELGIUM |
| Participating centres | | Istituto G. Gaslini (Genova) | | Fondazione Stella Maris (Calambrone (PI)) | | Ospedale Fatebenefratelli (Milano) | | Ospedale Pediatrico Bambin Gesł (Roma) |
|
